Fisher & Paykel Healthcare Ltd (FSPKF)
Fisher & Paykel Healthcare Ltd is a common stock listing on OTC Markets for a healthcare equipment company based in Auckland, New Zealand. Through its subsidiaries, the company develops, manufactures, markets, and sells medical device products and systems used in respiratory care and surgery, as well as in the treatment of obstructive sleep apnea in home and hospital settings. Its portfolio includes adult respiratory products such as the Airvo system, Optiflow nasal high flow therapy, and invasive and noninvasive ventilation solutions. The company also supplies infant respiratory products, along with hospital equipment and homecare products that include masks, CPAP devices, humidifiers, software and data management tools, and related accessories. Founded in 1934, Fisher & Paykel Healthcare serves customers across North America, Europe, the Asia Pacific, and other international markets.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-FSPK.F
|
$18.78
|
-18.0% Downside
|
Fair
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
September 2, 2026
|
49.8x
|
11.0x
|
10.1x
|
13.45 B
|
13.217 B
|
0.6%
|
99.7%
|
11.0
|
47.8%
|
104.7%
|
